A planned private treatment center
Neurologist-led TMS for Parkinson's disease, ataxia, brain fog and recovery after stroke.
Led by Sheng-Han Kuo, MD, movement disorder neurologist
Opening in Manhattan. By invitation.
The Approach
We are building a private treatment center for the brain, led by a neurologist. Care begins with a consultation and a baseline assessment that confirm the diagnosis and identify the symptoms that bother you most.
From there, the neurologist designs a TMS protocol tailored to you. Sessions are delivered by nurse practitioners and trained technicians, with regular check-ins from one care team.
Medical Leadership
Chief Medical Officer
Dr. Kuo cares for people with Parkinson's disease, ataxia and tremor, and leads research on how the cerebellum shapes movement. He designs every Neuon protocol and oversees each patient's assessment and plan.
Academic affiliation is listed for identification only. Neuon is independent of Columbia University and is not affiliated with or endorsed by it.
About TMS
TMS uses magnetic pulses, delivered through a coil placed against the scalp, to stimulate specific areas of the brain. It is noninvasive and does not require anesthesia.
TMS is not new. It was first demonstrated in 1985 and has been used in research and patient care for decades. It has been FDA cleared for depression since 2008.
Disclosure
TMS is cleared by the FDA for certain conditions, including depression. Its use for movement disorders and other neurological conditions, such as Parkinson's disease, ataxia, brain fog, or recovery after stroke, is not FDA cleared and would be offered off-label, under physician supervision, with informed consent.Where We Focus
Many Parkinson's symptoms respond poorly to standard medication, including freezing, speech, swallowing and mood. TMS over the motor areas of the brain has the most research behind it for movement symptoms, and is being studied for the others.
People with ataxia have few treatment options. TMS directed at the cerebellum is being studied for balance, walking, coordination, and speech. Our chief medical officer leads a dedicated ataxia and tremor research program.
TMS is being studied as a way to support recovery of movement and speech after a stroke.
Brain fog means slowed thinking, poor focus and trouble finding words, often after COVID, during illness or with age. TMS is being studied for thinking and attention. Research in brain fog is early.
Take the brain fog self-check.Results vary from person to person, and no outcome is guaranteed.
Who We Are Building For
People living with Parkinson's disease, ataxia, multiple system atrophy, or brain fog, people recovering after a stroke, and the families who help care for them.
Anyone interested in brain health is welcome to join the list.
How It Would Work
About 90 minutes. A safety screen, baseline measures and your personal stimulation level.
Ten 30-minute sessions, five days a week for two weeks.
On day 14 we repeat your measures and review the change with you.
We measure again at one and three months. If the first protocol does not help, we change to another.
A monthly plan, or a booster week every three months if you travel.
A Different Model
Neuon is designed to complement care from your own neurologist, not replace it.
The Founding Program
Ten sessions over about two weeks, with assessment before and after.
HSA and FSA eligibility depends on your plan. Check with your plan administrator.
Founding pricing is for planning purposes and may change. Joining the list carries no obligation.
Questions
Interest List
Join the list and we will be in touch as plans develop.